Emil Scosyrev

2.4k total citations · 2 hit papers
44 papers, 1.5k citations indexed

About

Emil Scosyrev is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Statistics and Probability. According to data from OpenAlex, Emil Scosyrev has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Statistics and Probability. Recurrent topics in Emil Scosyrev's work include Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (10 papers) and Statistical Methods in Clinical Trials (9 papers). Emil Scosyrev is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (10 papers) and Statistical Methods in Clinical Trials (9 papers). Emil Scosyrev collaborates with scholars based in United States, Switzerland and Belgium. Emil Scosyrev's co-authors include Edward M. Messing, Richard Sylvester, Hendrik Van Poppel, Katia Noyes, Steven C. Campbell, Changyong Feng, Guan Wu, Dragan Golijanin, Supriya G. Mohile and Jorge L. Yao and has published in prestigious journals such as Cancer, The Journal of Urology and European Urology.

In The Last Decade

Emil Scosyrev

43 papers receiving 1.5k citations

Hit Papers

Renal Function After Nephron-sparing Surgery Versus Radic... 2013 2026 2017 2021 2013 2023 100 200 300

Peers

Emil Scosyrev
Reza Ghavamian United States
Jeffrey Tomaszewski United States
Kenneth G. Nepple United States
Adam C. Reese United States
Reza Ghavamian United States
Emil Scosyrev
Citations per year, relative to Emil Scosyrev Emil Scosyrev (= 1×) peers Reza Ghavamian

Countries citing papers authored by Emil Scosyrev

Since Specialization
Citations

This map shows the geographic impact of Emil Scosyrev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Scosyrev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Scosyrev more than expected).

Fields of papers citing papers by Emil Scosyrev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Scosyrev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Scosyrev. The network helps show where Emil Scosyrev may publish in the future.

Co-authorship network of co-authors of Emil Scosyrev

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Scosyrev. A scholar is included among the top collaborators of Emil Scosyrev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Scosyrev. Emil Scosyrev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scosyrev, Emil, et al.. (2023). Global prevalence of Rett syndrome: systematic review and meta-analysis. Systematic Reviews. 12(1). 5–5. 65 indexed citations breakdown →
2.
Scosyrev, Emil, Richard N. van Zyl-Smit, Huib A.M. Kerstjens, et al.. (2021). Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials. Respiratory Medicine. 180. 106311–106311. 8 indexed citations
3.
Scosyrev, Emil, et al.. (2017). Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?. Clinical Drug Investigation. 37(5). 415–422. 77 indexed citations
4.
Scosyrev, Emil, Edward M. Messing, Richard Sylvester, & Hendrik Van Poppel. (2017). Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy. European Urology Focus. 3(6). 599–605. 13 indexed citations
5.
Kukreja, Janet Baack, Emil Scosyrev, Maureen Kiernan, et al.. (2015). Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery. Urologic Oncology Seminars and Original Investigations. 33(9). 387.e7–387.e16. 37 indexed citations
7.
Scosyrev, Emil, et al.. (2013). Sex differences in incidence and mortality of bladder and kidney cancers: National estimates from 49 countries. Urologic Oncology Seminars and Original Investigations. 32(1). 40.e23–40.e31. 31 indexed citations
8.
Scosyrev, Emil, Edward M. Messing, Richard Sylvester, Steven C. Campbell, & Hendrik Van Poppel. (2013). Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904. European Urology. 65(2). 372–377. 356 indexed citations breakdown →
9.
Scosyrev, Emil, Guan Wu, Dragan Golijanin, & Edward M. Messing. (2012). Prostate‐specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system. British Journal of Urology. 110(10). 1485–1490. 20 indexed citations
10.
Scosyrev, Emil. (2012). Identification of causal effects using instrumental variables in randomized trials with stochastic compliance. Biometrical Journal. 55(1). 97–113. 26 indexed citations
11.
Scosyrev, Emil, Scott Tobis, Guan Wu, et al.. (2012). Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta‐analysis of eight cohort studies. British Journal of Urology. 111(3b). E71–7. 43 indexed citations
12.
Scosyrev, Emil, Edward M. Messing, Edwin van Wijngaarden, et al.. (2011). Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer. 118(1). 72–81. 43 indexed citations
13.
Scosyrev, Emil, Edward M. Messing, Supriya G. Mohile, Dragan Golijanin, & Guan Wu. (2011). Prostate cancer in the elderly. Cancer. 118(12). 3062–3070. 127 indexed citations
14.
Scosyrev, Emil, Dragan Golijanin, Guan Wu, & Edward M. Messing. (2011). The burden of bladder cancer in men and women: analysis of the years of life lost. British Journal of Urology. 109(1). 57–62. 20 indexed citations
15.
Scosyrev, Emil, Jorge L. Yao, & Edward M. Messing. (2010). Microscopic Invasion of Perivesical Fat by Urothelial Carcinoma: Implications for Prognosis and Pathology Practice. Urology. 76(4). 908–913. 15 indexed citations
17.
Scosyrev, Emil, et al.. (2010). Female bladder cancer: incidence, treatment, and outcome. Current Opinion in Urology. 20(5). 404–408. 23 indexed citations
18.
Scosyrev, Emil, James Messing, Katia Noyes, Peter J. Veazie, & Edward M. Messing. (2010). Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview. Urologic Oncology Seminars and Original Investigations. 30(2). 126–132. 74 indexed citations
19.
Scosyrev, Emil, Jorge L. Yao, & Edward M. Messing. (2009). Urothelial Carcinoma Versus Squamous Cell Carcinoma of Bladder: Is Survival Different With Stage Adjustment?. Urology. 73(4). 822–827. 79 indexed citations
20.
Scosyrev, Emil, Katia Noyes, Changyong Feng, & Edward M. Messing. (2008). Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 115(1). 68–74. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026